Achieve Life Sciences (STU:SP4P) Operating Cash Flow per Share : €-0.74 (TTM As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Achieve Life Sciences Operating Cash Flow per Share?

Achieve Life Sciences's operating cash flow per share for the three months ended in Jun. 2024 was €-0.13. Achieve Life Sciences's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.74.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 37.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 53.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 55.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Achieve Life Sciences's Operating Cash Flow per Share or its related term are showing as below:

STU:SP4P' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -328.9 Med: 27.4 Max: 85.9
Current: 37.1

During the past 13 years, Achieve Life Sciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 85.90% per year. The lowest was -328.90% per year. And the median was 27.40% per year.

STU:SP4P's 3-Year OCF Growth Rate is ranked better than
84.8% of 1197 companies
in the Biotechnology industry
Industry Median: 3.5 vs STU:SP4P: 37.10

Achieve Life Sciences Operating Cash Flow per Share Historical Data

The historical data trend for Achieve Life Sciences's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences Operating Cash Flow per Share Chart

Achieve Life Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-33.24

-4.07

-3.21

-3.35

-1.13

Achieve Life Sciences Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.32	-0.23	-0.19	-0.19	-0.13

Competitive Comparison of Achieve Life Sciences's Operating Cash Flow per Share

For the Biotechnology subindustry, Achieve Life Sciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achieve Life Sciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's Price-to-Operating-Cash-Flow falls into.

Achieve Life Sciences Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Achieve Life Sciences's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-22.447	/	19.827
	=	-1.13

Achieve Life Sciences's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )	=	Cash Flow from Operations (Q: Jun. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
	=	-4.572	/	34.319
	=	-0.13

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.74

Achieve Life Sciences Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Achieve Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (STU:SP4P) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

ACHV:USA

Address

22722 29th Dr. SE, Suite 1000, Bothell, WA, USA, 98021

Website

https://www.achievelifesciences.com

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Achieve Life Sciences Headlines

No Headlines